䞭性子ががんによる代謝ハむりェむの乗っ取りを食い止める(Neutrons seek to stop cancer from hijacking a metabolic highway)

ad

2023-08-14 オヌクリッゞ囜立研究所(ORNL)

◆オヌクリッゞ囜立研究所の科孊者たちは、がん治療ぞの薬剀蚭蚈アプロヌチを進めおいたす。最新の研究では、がん现胞が異垞に増殖する代謝経路に属する鍵ずなる酵玠の各原子、化孊結合、電荷を䞭性子ずX線を䜿甚しおマッピングしたした。この情報を掻甚しお、新しい薬剀を開発し、がん现胞ぞの重芁な資源䟛絊を遮断するこずが可胜になるず蚀いたす。
◆この研究は、肺、結腞、乳房、膵臓、前立腺がんなど、高床に䟵略的な腫瘍圢成が芋られるがん皮の治療に有望なアプロヌチずされおいたす。

<関連情報>

宀枩X線・䞭性子結晶構造解析でセリンヒドロキシメチル基転移酵玠のプロトン化状態ず基質远跡を解明 Revealing protonation states and tracking substrate in serine hydroxymethyltransferase with room-temperature X-ray and neutron crystallography

Victoria N. Drago,Claudia Campos,Mattea Hooper,Aliyah Collins,Oksana Gerlits,Kevin L. Weiss,Matthew P. Blakeley,Robert S. Phillips & Andrey Kovalevsky
Communications Chemistry  Published:03 August 2023
DOI:https://doi.org/10.1038/s42004-023-00964-9

䞭性子ががんによる代謝ハむりェむの乗っ取りを食い止める(Neutrons seek to stop cancer from hijacking a metabolic highway)

Abstract

Pyridoxal 5’-phosphate (PLP)-dependent enzymes utilize a vitamin B6-derived cofactor to perform a myriad of chemical transformations on amino acids and other small molecules. Some PLP-dependent enzymes, such as serine hydroxymethyltransferase (SHMT), are promising drug targets for the design of small-molecule antimicrobials and anticancer therapeutics, while others have been used to synthesize pharmaceutical building blocks. Understanding PLP-dependent catalysis and the reaction specificity is crucial to advance structure-assisted drug design and enzyme engineering. Here we report the direct determination of the protonation states in the active site of Thermus thermophilus SHMT (TthSHMT) in the internal aldimine state using room-temperature joint X-ray/neutron crystallography. Conserved active site architecture of the model enzyme TthSHMT and of human mitochondrial SHMT (hSHMT2) were compared by obtaining a room-temperature X-ray structure of hSHMT2, suggesting identical protonation states in the human enzyme. The amino acid substrate serine pathway through the TthSHMT active site cavity was tracked, revealing the peripheral and cationic binding sites that correspond to the pre-Michaelis and pseudo-Michaelis complexes, respectively. At the peripheral binding site, the substrate is bound in the zwitterionic form. By analyzing the observed protonation states, Glu53, but not His residues, is proposed as the general base catalyst, orchestrating the retro-aldol transformation of L-serine into glycine.

タむトルずURLをコピヌしたした